Abstracts

Submission Deadline Extended


Abstract submissions have been extended to September 30, 2019 (11:59 PM CDT).  Late submissions will not be accepted.

If you require special permissions or authorizations with regards to your abstract, they must be received prior to submission. If you are unsure if you have applied for and received permission to use a rating scale owned by MDS, please visit the Rating Scales webpage for more information.

Submit Abstract

Open AllClose All
  Eligibility

The International Parkinson and Movement Disorder Society invites all MDS members and non-members to submit an abstract for review for the ES Summit.

Please note the following criteria:

  • There is no fee to submit an abstract
  • All abstract submissions must be original research
  • All abstracts must be submitted and presented in English
  • Abstracts that have been presented at other meetings may be submitted if they have not been published and if the meeting name and date are cited accordingly
  • If your abstract is accepted, you must be prepared to travel to the ES Summit to present your abstract on the assigned date
  Terms and Conditions

MDS expects that all abstracts selected for presentation will be presented by the original author(s) and that no submitted abstracts will be withdrawn. Please do not submit an abstract if you are not prepared to travel to the meeting and present it in the session selected by MDS.

Attendance is required. Accepted abstracts must have a presenter in attendance at the ES Summit in Venice, Italy to present their poster(s), and should plan to attend from March 18-20, 2020 as poster presentation dates are subject to change. It is not mandatory that the first author be pre-registered and present; the presenter may be any of the contributing authors, or a colleague.

MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or of the group. Should plagiarism be detected, the abstract will be rejected.

All abstracts accepted for presentation may be published in an electronic supplement to the Movement Disorders Clinical Practice Journal, online edition

All submitted abstracts become the property of MDS.

  Abstract Submission Format

Please read the following section before submitting your abstract for review. View examples of MDS abstracts.

Please limit the total abstract text to 2,500 characters (including spaces). The size limit includes Abstract Title and Abstract Body. Please refrain from using special characters within the abstract text.

Abstract should adhere to the following format:

  • Objective (250 characters)
  • Background (250 characters)
  • Methods (250 characters)
  • Results (250 characters)
  • Conclusions (250 characters)
  • References (250 characters)

You will be asked to list the name, affiliation and e-mail for each co-author. However, all communications and notifications regarding abstract submissions will be sent only to the submitting author.

You may upload up to three files. The size limit for each file is 4MB.

The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands. Non-proprietary (generic) drug names should be used and should be written without capitals.

If you are including tables or figures within your abstract, you must enter the appropriate ID tag in the abstract body where you would like your tables and/or figures to appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure. You may upload the tables within the abstract submission system

  Review Process

The ES Summit Scientific Program Committee will review all abstracts. Authors were required to select one category under which their abstract should be reviewed.

The Committee shall be directed to reject abstracts for the following causes:

  • Plagiarism detected
  • Marketing
  • Subject not related to the field of Movement Disorders
  • Does not meet basic submission requirements
  Changing or Withdrawing an Abstract

Changes after abstract has been submitted are strongly discouraged! If critical changes need to be made to your abstract content after it has been submitted, please request those changes by email to essummit@movementdisorders.org

Changes to your submitted abstract will not be accepted after October 21, 2019.

If an abstract must be withdrawn for any reason, please contact essummit@movementdisorders.org as soon as possible. Withdrawals must be received in writing by November 1, 2020. There is no penalty to withdraw your abstract, however if your withdrawal request is received after the abstracts have been sent for publication, it cannot be withdrawn and will remain a part of the 2020 MDS published abstracts. All submitted abstracts become the property of MDS.

  Publication

Abstracts accepted for presentation will be published in an electronic supplement to the Movement Disorders Clinical Practice Journal, online edition.

Important Dates

September 9, 2019
Registration and Housing Open

September 30, 2019
Abstract Submission and Travel Grant Applications Close

March 18-20, 2020
ES Summit: Therapeutic Milestones in Parkinson’s Disease

For More Information

International Secretariat
555 East Wells Street, Suite 1100
Milwaukee, WI 53202 USA
Phone: +1 414-276-2145
Fax: +1 414-276-3349
Email: essummit@movementdisorders.org
 

Top